IURLO A, CATTANEO D, BOIOCCHI L, OROFINO N, FERMO E, CORTELEZZI A, GIANELLI U.
“CLINICAL AND MORPHOLOGIC FEATURES IN FIVE POST-POLYCYTHEMIC MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB”
Ann Hematol. 2015 Oct;94(10):1749-51.
IURLO A, ORSI E, CATTANEO D, RESI V, BUCELLI C, OROFINO N, SCIUME’ M, ELENA C, GRANCINI V, CONSONNI D, ORLANDI EM, CORTELEZZI A.
“EFFECTS OF FIRST- AND SECOND-GENERATION TYROSINE KINASE INHIBITOR THERAPY ON GLUCOSE AND LIPID METABOLISM IN CHRONIC MYELOID LEUKEMIA PATIENTS: A REAL CLINICAL PROBLEM?”
Oncotarget. 2015 Oct 20;6(32):33944-51.
CATTANEO D, MOROTTI D, BUCELLI C, CANNONE M, ZAPPA M, GUERNERI S, IURLO A.
“COMPREHENSIVE MOLECULAR ANALYSES IN A CASE OF MASKED PHILADELPHIA CHRONIC MYELOID LEUKEMIA”
Cytogenet Genome Res. 2015;147(1):35-40.
COMUNICAZIONI A CONGRESSI
OLIVEIRA G, CASERA C, BUCCI G, TOFFALORI C, GARCIA-MANTEIGA JM, CAMISA B, LAZAREVIC D, CRUCITTI L, ZITO L, CARRABBA M, BERNARDI M, BIANCHI M, BONDANZA A, CICERI F, BONINI C, VAGO L.
“AN INNOVATIVE HUMANIZED MOUSE MODEL TO INVESTIGATE THE INTERPLAY BETWEEN IMMUNE
SYSTEM AND ACUTE MYELOID LEUKEMIA IN ALLOGENEIC HSCT”
